












































The American Journal of Cardiovascular Drugs, the official journal of the International Academy of Cardiovascular Sciences, promotes rational therapy and disease management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures.
The journal includes:
* current opinion articles providing an overview of contentious or emerging areas and key regulatory and ethical issues
* definitive reviews on a broad range of topics relating to the management of cardiovascular disorders
* therapy in practice articles covering optimum management of specific conditions
* Adis Drug Evaluations which review the properties and place in therapy of both newer and established drugs and devices in cardiology
* Adis Drug Profiles of recently released cardiovascular drugs and devices - a timely and invaluable resource reflecting the cutting edge of therapeutic improvements
* selected high-quality original clinical research articles





